Task Group Charge
To address the broad challenges related to lung cancer survivorship across the care continuum, and the influence that stigma and nihilism have on quality of life, cancer care and prognosis.
Leadership
Jamie L. Studts, PhD
Task Group Chair
Steering Committee Member
University of Colorado School of Medicine
Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN
Task Group Vice Chair
Memorial Sloan Kettering Cancer Center
Task Group Members
Nancy Alvey
Survivor and Lung Cancer Advocate, Kentucky LEADS Collaborative
Abbie Begnaud, MD
University of Minnesota
Deborah Brown
American Lung Association
Andrew Chang, MD
University of Michigan
Deena Cook
Survivor and Lung Cancer Advocate, GO2 Foundation for Lung Cancer
Dusty Donaldson, MA
Survivor and Lung Cancer Advocate, Dusty Joy Foundation (LiveLung)
Heidi Hamann, PhD
University of Arizona
Drew Moghanaki, MD, MPH
Emory Healthcare and Atlanta VA Healthcare System
Jamie Ostroff, PhD*
Memorial Sloan Kettering Cancer Center
James Pantelas
Survivor and Lung Cancer Advocate, GO2 Foundation for Lung Cancer
Elyse Park, PhD, MPH
Massachusetts General Hospital
Maureen Rigney, LISCW
GO2 Foundation for Lung Cancer
Elizabeth Rohan, PhD, MSW
Centers for Disease Control and Prevention
Pamela Samson, MD, MPHS
Washington University School of Medicine in St. Louis
Joan Schiller, MD
Lung Cancer Research Foundation
Brendon Stiles, MD
Weill Cornell Medicine
(*) indicates Steering Committee member
Opportunities For Intervention/Influence:
- Meet the survivorship needs of patients and families living with, through and beyond lung cancer
- Address stigma across the lung cancer control continuum with the goal of eliminating stigma as an obstacle to quality of life, care delivery, and health outcomes
- Identify and address the causes and impact of nihilism regarding lung cancer risk reduction, screening, diagnosis and treatment